Altimmune
Price & Volume
Stats
See more52W Range | $2.56-$6.44 |
Market Cap | $558.1M |
Shares Short | 47M |
Financials
See moreRevenue (12 Mos) | $36,000 |
Revenue Growth (YoY) | 420% |
Gross Profit (12 Mos) | -$66M |
Diluted EPS | -$0.92 |
News
See moreYahoo Finance • 16 days ago
Leerink Sees Altimmune (ALT) As An Attractive Play In The MASH Therapeutics Market
Yahoo Finance • last month
Altimmune shifts headquarters to New Jersey, targeting biopharma talent and cost savings
Yahoo Finance • last month
Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight
Yahoo Finance • 2 months ago
GLP-1 Sales Forecast Jumps To $150 Billion By 2030
About
CEO | Mr. Jerome Benedict Durso |
Address | 910 Clopper Road, Gaithersburg, MD, United States, 20878 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 57 |